Evidence map›Paper›PMID 30789124›Full record

ArticleEmerging infectious diseases2019

Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.

Salam El Achkar, Christine Demanche, Marwan Osman, Rayane Rafei, Mohamad Bachar Ismail, Hiam Yaacoub, Claire Pinçon, Stéphanie Duthoy, Frédérique De Matos, Cyril Gaudin and 4 more

Open access · diamondAbstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 3 countries.

Salam El Achkar
Christine Demanche
Marwan Osman
Rayane Rafei
Mohamad Bachar Ismail
Hiam Yaacoub
Claire Pinçon
Stéphanie Duthoy
Frédérique De Matos
Cyril Gaudin
Alberto Trovato
Daniela M Cirillo
Monzer Hamze
Philip Supply
Istituti di Ricovero e Cura a Carattere Scientifico · ITVita-Salute San Raffaele University · ITCenter for Infection and Immunity of Lille · FRInserm · FRInstitut Pasteur de Lille · FRIRCCS Ospedale San Raffaele · ITLebanese University · LBUniversité de Lille · FRUniversity of Tripoli Lebanon · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a 12-month nationwide study on the prevalence of drug-resistant tuberculosis (TB) in Lebanon, we identified 3 multidrug-resistant cases and 3 extensively drug-resistant TB cases in refugees, migrants, and 1 Lebanon resident. Enhanced diagnostics, particularly in major destinations for refugees, asylum seekers, and migrant workers, can inform treatment decisions and may help prevent the spread of drug-resistant TB.

Indexed as

Drug Resistance, Multiple, BacterialMycobacterium tuberculosisAdultAntitubercular AgentsFemaleGenes, BacterialGenotypeHistory, 21st CenturyHumansLebanonMaleMicrobial Sensitivity TestsMiddle AgedMinisatellite RepeatsMutationTuberculosis, Multidrug-ResistantAntitubercular Agentsantimicrobial resistanceasylum seekersbacteriaDNA sequencingdrug resistanceLebanonMDRmigrant workersrefugeessurveyTBTuberculosistuberculosis and other mycobacteriawhole-genome sequencingXDR

Identifiers

PMID30789124
PMCPMC6390733
OpenAlexW2911600410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.